Immunology Notes: T Cells and B Cells
T Cell Markers and MHC Presentation
- Identify CD markers on T cells:
- Helper T cells express .
- Cytotoxic T cells express .
- Identify which MHC presents to different T cell types:
- MHC I presents peptides to cytotoxic T cells.
- MHC II presents peptides to helper T cells.
- Why this matters:
- Determines which T cell subset can recognize which antigen-presenting cell.
- Drives the division of labor in adaptive immunity (cell-mediated vs humoral responses).
Major T Cell Types and Their Functions
- Naive T cells differentiate into several effector and memory subsets:
- Th1 cells: promote cell-mediated immunity; activate macrophages; secrete IFN-γ; important against intracellular pathogens.
- Transcription factor: T-bet.
- Th2 cells: support humoral immunity and B cell activation; promote class switching to certain antibody isotypes; secrete IL-4, IL-5, IL-13; important for defense against helminths and involved in allergic responses.
- Transcription factor: GATA-3.
- Th17 cells: recruit neutrophils and are important for defense against extracellular bacteria and fungi; secrete IL-17 family cytokines; implicated in autoimmunity when dysregulated.
- Transcription factor: RORγt.
- Tfh (T follicular helper) cells: provide help to B cells in germinal centers; promote affinity maturation and class switching; secrete IL-21.
- Transcription factor: Bcl-6.
- Treg (Regulatory T cells): maintain self-tolerance and limit immune responses; suppress autoimmunity.
- Markers and function: expression of FoxP3, CD25; mechanisms include CTLA-4 and anti-inflammatory cytokines (e.g., IL-10, TGF-β).
- Cytotoxic T cells (CTLs, CD8^+): kill infected or abnormal cells via perforin/granzyme pathways; recognize peptide–MHC I complexes; crucial for eliminating intracellular pathogens and tumor cells; can form memory CTLs.
- Memory T cells:
- Central memory (Tcm): reside in lymph nodes; rapid proliferation upon antigen re-encounter.
- Effector memory (Tem): circulate in blood/tissues; ready to exert immediate effector functions.
- Activation and differentiation cues (two-signal model):
- Signal 1: TCR recognition of peptide–MHC complex (via the CD3 complex).
- Signal 2: Co-stimulation (e.g., on T cells binding to on APCs).
- Cytokine milieu guiding differentiation into specific helper or cytotoxic subsets.
- Key signaling and transcription landscape:
- Th1: transcription factor T-bet; IFN-γ production.
- Th2: transcription factor GATA3; IL-4, IL-5, IL-13 production.
- Th17: transcription factor RORγt; IL-17 family cytokines.
- Tfh: transcription factor Bcl-6; IL-21 production.
- Treg: transcription factor FoxP3; CTLA-4; regulatory cytokines.
- Interplay and coordination:
- Th cells coordinate B cell help and cytotoxic responses depending on the pathogen.
- Regulatory cells help prevent collateral tissue damage and autoimmunity.
- Connections to foundational principles:
- Adaptive immunity relies on specificity, clonal expansion, and memory.
- APCs bridge innate sensing to tailored T cell responses via antigen processing and presentation.
- The two-signal requirement minimizes accidental activation and autoimmunity.
- Real-world relevance:
- Vaccines aim to elicit robust Th and B cell responses for durable protection.
- Immunotherapies target T cell subsets (e.g., enhancing CD8^+ responses in cancer, modulating Treg activity in autoimmunity).
- Numerical references, formulas, and key values:
- Peptide lengths commonly presented:
- MHC I: amino acids.
- MHC II: amino acids.
- Activation signals: typically at least two signals (Signal 1 + Signal 2), plus cytokine cues for differentiation.
B Cell Activation and Differentiation into Plasma Cells
Overview of B cell activation:
- Antigen binding to B cell receptor (BCR) triggers receptor cross-linking and internalization for processing.
- B cells present processed peptides on MHC II to helper T cells and receive help via CD40–CD40L interactions and cytokines (e.g., IL-4, IL-5).
TD (T-dependent) vs TI (T-independent) activation:
- TD antigens: proteins; require T cell help; typical outcome includes germinal center formation and long-lasting humoral immunity.
- TI antigens: polysaccharides or repetitive structures; can activate B cells without T cell help (TI-1, TI-2); responses are often weaker and less class-switched.
Germinal center reactions (TD pathway):
- B cells proliferate in germinal centers of lymph nodes/spleen.
- Somatic hypermutation: introduces mutations in variable regions to increase antibody affinity.
- Class switch recombination: changes antibody isotype (e.g., IgM to IgG, IgA, or IgE) depending on cytokines and CD40 signaling.
- Selection for higher-affinity BCRs ensures more effective antibodies.
Differentiation outcomes:
- Plasma cells: antibody-secreting cells produced from B cells; secrete antibodies of various isotypes with different effector functions (neutralization, opsonization, complement activation).
- Memory B cells: long-lived cells that provide rapid and robust antibody responses upon re-exposure.
Isotype switching cues (cytokine influence):
- IL-4 promotes switching to IgG1 and IgE in humans (context-dependent isotype patterns).
- IFN-γ promotes switching to IgG2.
Antibody functions (brief):
- Neutralization of pathogens/toxins.
- Opsonization for phagocytosis.
- Complement activation via classical pathway.
- Fc receptor-mediated effector functions.
Clinical relevance:
- Vaccines rely on eliciting high-affinity antibodies and memory B cell formation for lasting protection.
- Immunodeficiencies affecting B cells or T-B collaboration can lead to poor vaccine responses.
Notable metaphors/examples:
- BCR–antigen interaction as a lock-and-key mechanism; germinal center reactions as a training ground to fine-tune antibody quality.
Connections to foundational principles:
- Humoral immunity is generated through B cell receptor–antigen recognition and T cell help, enabling targeted antibody responses.
- The interplay between B cells and T helper cells shapes affinity maturation and isotype distribution.
Ethical, philosophical, and practical implications:
- Designing vaccines and immunotherapies requires understanding how to steer T helper responses and B cell maturation without triggering autoimmunity.
- Personalized vaccines may consider individual HLA/MHC makeup and T cell repertoire to optimize responses.